In this review:
Rivaroxaban ± aspirin in stable cardiovascular disease (COMPASS)
COMPASS trial results in subgroup with PAD
Dual antithrombotic therapy with dabigatran after PCI in AF (RE-DUAL)
Apixaban in patients with AF undergoing cardioversion (EMANATE)
Catheter ablation in patients with LV dysfunction and AF (CASTLE-AF)
State-of-the-art PCI in patients with 3 vessel disease (SYNTAX II)
Have we reached the bottom line in mortality after acute MI?
Antiinflammatory therapy with canakinumab for atherosclerotic disease
Oxygen therapy in suspected acute MI (DETO2X-AMI)
Renal denervation for uncontrolled hypertension (SPYRAL HTN-OFF MED)
Efficacy of beta-blockers in heart failure according to LVEF
Please login below to download this issue (PDF)